Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Aoxing Pharmaceutical Company Inc (NYSE MKT: AXN) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Aoxing Pharmaceutical Company Inc (NYSE MKT: AXN)  concerning whether a series of statements by Aoxing Pharmaceutical Company Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On December 1, 2015, after-market, Aoxing Pharmaceutical Company Inc stated that Wilfred Chow, Chief Financial Officer of Aoxing Pharmaceutical Company resigned on November 30, 2015.

After this news was released, the company's stock fell $0.07, or 5.11%, to close at $1.30 on December 2, 2015.

Based in Shijiazhuang, China, and founded in 1655 Aoxing Pharmaceutical Company Inc is a specialty pharmaceutical company, which specializes in research, development, manufacturing and distribution of a range of narcotics and pain-management products and drug-relief medicine.

If you purchased shares of Aoxing Pharmaceutical Company Inc (NYSE MKT: AXN) on or before December 1, 2015, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185